New daily diabetes pill that helps with weight loss launches in UK pharmacies
Foundayo will be available on private prescription, with pharmacists warning of counterfeit GLP-1 problem
TL;DR
- A new daily pill for diabetes and weight loss, Orforglipron (Foundayo), is now available in UK pharmacies.
- The UK is the first country in Europe to approve this oral treatment, which is made by Eli Lilly.
- It is licensed for individuals with a BMI of 30 or above, or those with a BMI between 27-30 and a weight-related condition, and for improving blood sugar in type 2 diabetes.
- Foundayo is initially available via private prescription, with plans for potential rollout on the NHS.
- Pharmacists have warned about the increasing problem of fake, unlicensed, or counterfeit GLP-1 tablets.
- There are concerns that fake pills are easier to produce than injectables, and authorities have seized counterfeit products.